article thumbnail

Entry-Level Pharma Sales: It's More Than Just a Job Search (Here's Why)

Contrarian Sales Techniques

Are your interest piqued by the words ‘pharmaceutical sales’? Let’s look at the exciting possibilities, essential skills, and valuable resources that can prepare you for success with the entry-level pharmaceutical sales. Internships: While less common than seeking full-time jobs, this could still be a possible intent.

Sales 52
article thumbnail

Global cell line development to surge in next decade

European Pharmaceutical Review

Total cell line product sales are expected to reach $3,124.4 Advancements in biotechnology, pharmaceutical research, and biomanufacturing processes are key factors in driving the market, the author acknowledged. The global cell line development industry is expected to value $4,674.8 percent through the next decade.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Pharmaceutical Patents: A Challenge for Malaysia

Contrarian Sales Techniques

The paper was presented at the International Conference on Pharmaceutical Research and Development (IPRDC) in Kuala Lumpur, Malaysia, in June 2017. It is noteworthy that Malaysia has a pharmaceutical manufacturing sector that almost exclusively produces generic drugs, with sales revenues amounting to only 1.5%

article thumbnail

The Traditional Pharma Model Isn’t Working – It’s Time to Evolve!

PharmaKinnex

– Inefficient & Expensive Sales Strategies. Without a robust and remote supplementary sales strategy, many of these pharma marketing companies have been left scrambling in a new environment where their old techniques don’t work and they’re not sure how to move forward with the new ones. – New & Updated Legislation.

Pharma 52
article thumbnail

Beating the Big C

Pharmaceutical Technology

It has boosted anti-tumour research by 60% since 2005, at a cost of $1.6bn, in the hope of increasing the share of company sales attributed to cancer drugs from the current level of 5% “There are a lot of patients that are suffering,” said Pfizer chief executive Jeffrey Kindler.

article thumbnail

US Democrats’ blockbuster budget bill could spell big changes for drug prices

pharmaphorum

Chief among these provisions is that the bill will allow, and indeed require, Medicare, the US’s government-run insurance program for older Americans, to negotiate drug prices with pharmaceutical companies in some cases, something it historically has not been allowed to do.